Attenuated mutant newcastle disease virus strains for in ovo vaccination, method for preparing and their use
US7252984B2 · kind B2 · utility
1Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 2002 |
| Grant date | Aug 7, 2007 |
| Priority date | — |
| Expiry date | Dec 17, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new attenuated mutant New Castle's disease La SotaNewcastle disease virus strains suitable for in ovo vaccination of avian species comprising a mutation in the gene sequences encoding the HN and/or F glycoproteins of said virus. Furthermore, the invention relates to a vaccine composition comprising said attenuated mutant Newcastle's disease La Sota virus strain, and to the use thereof for the preparation of a vaccine for in ovo vaccination of avian species against Newcastle's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.